Is Oscar Health (OSCR) a Smart Long-Term Buy?

Longleaf Partners Fund, a Memphis-based fund under Southeastern Asset Management, published its “Longleaf Partners Small-Cap Fund” second quarter 2022 investor letter – a copy of which can be downloaded here. Longleaf Partners Small-Cap Fund declined 15.66% in the second quarter, outperforming the Russell 2000 Index, which declined 17.20%, and roughly in line with the Russell 2000 Value. Go over the fund’s top 5 positions to have a glimpse of its finest picks for 2022.

In its Q2 2022 investor letter, Longleaf Partners Fund mentioned Oscar Health, Inc. (NYSE:OSCR) and explained its insights for the company. Founded in YEAR, Oscar Health, Inc. (NYSE:OSCR) is a HEADQUARTERS-based health insurance company with a $1.1 billion market capitalization. Oscar Health, Inc. (NYSE:OSCR) delivered a -30.70% return since the beginning of the year, while its 12-month returns are down by -68.90%. The stock closed at $5.44 per share on September 20, 2022.

 Here is what Longleaf Partners Fund has to say about Oscar Health, Inc. (NYSE:OSCR) in its Q2 2022 investor letter:

“Oscar Health – US health insurance and software platform Oscar Health, a new position purchased in 4Q21, declined alongside most tech-related businesses in the quarter. The market is not recognizing the meaningful value of its managed care plan members and is instead focusing on near-term EBITDA declines driven by the company rapidly growing its health insurance and software businesses. Our management partners are aligned and have a track record of adding value for shareholders.”

Iakov Filimonov/Shutterstock.com

Our calculations show that Oscar Health, Inc. (NYSE:OSCR) fell short and didn’t make it on our list of the 30 Most Popular Stocks Among Hedge Funds. Oscar Health, Inc. (NYSE:OSCR) was in 16 hedge fund portfolios at the end of the second quarter of 2022, compared to 29 funds in the previous quarter. Oscar Health, Inc. (NYSE:OSCR) delivered a 25.06% return in the past 3 months. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters 2022 Q2 page.

Disclosure: None. This article is originally published at Insider Monkey.